2-Bromo-3-chloro-5-methylpyridine | CAS:65550-81-4

We serve 2-Bromo-3-chloro-5-methylpyridine CAS:65550-81-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-Bromo-3-chloro-5-methylpyridine

Chemical Name:2-Bromo-3-chloro-5-methylpyridine
CAS.NO:65550-81-4
Synonyms:2-Bromo-3-chloro-5-methylpyridine
 
Physical and Chemical Properties:
Density 1.6±0.1 g/cm3
Boiling Point 254.5±35.0 °C at 760 mmHg
Molecular Formula C6H5BrClN
Molecular Weight 206.468
Flash Point 107.7±25.9 °C
Vapour Pressure 0.0±0.5 mmHg at 25°C
Index of Refraction 1.571
 
Specification:
Appearance:Light yellow crystalline powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.



Contact us for information like 2-Bromo-3-chloro-5-methylpyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Bromo-3-chloro-5-methylpyridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Bromo-3-chloro-5-methylpyridine Use and application,2-Bromo-3-chloro-5-methylpyridine technical grade,usp/ep/jp grade.


Related News: People who have returned to the UK from Wuhan in China are being told to stay in for 14 days, and to “self-isolate”.Pigment Yellow 154 manufacturer The Company has established a leadership position in the clinical development and manufacture of universal, off-the-shelf cell products using its proprietary induced pluripotent stem cell (iPSC) product platform.4-Fluoro-2-hydroxybenzoic acid supplier The Company has established a leadership position in the clinical development and manufacture of universal, off-the-shelf cell products using its proprietary induced pluripotent stem cell (iPSC) product platform.Pyridinium Tribromide vendor But the ban from Italy remains, Joseph Wu, Taiwan’s foreign minister, said on Sunday.It is understood that at present, the industry competition for global characteristic APIs has shown a development trend of vertical integration, and the number of mergers and acquisitions between pharmaceutical manufacturers and API manufacturers is increasing.